Mathilde Feist

845 total citations
15 papers, 665 citations indexed

About

Mathilde Feist is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, Mathilde Feist has authored 15 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Genetics and 6 papers in Surgery. Recurrent topics in Mathilde Feist's work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Mathilde Feist is often cited by papers focused on Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Mathilde Feist collaborates with scholars based in Germany, United States and China. Mathilde Feist's co-authors include Zong Sheng Guo, Zuqiang Liu, David L. Bartlett, Enyong Dai, Binfeng Lu, Walter J. Storkus, Congrong Ma, Stacy J. Kowalsky, Weilin Liu and Yukai He and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Molecular Therapy.

In The Last Decade

Mathilde Feist

14 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathilde Feist Germany	10	439	398	234	203	97	15	665
Kevin G. Shim United States	13	374 0.9×	318 0.8×	219 0.9×	215 1.1×	66 0.7×	28	634
Shyambabu Chaurasiya United States	18	406 0.9×	414 1.0×	203 0.9×	128 0.6×	124 1.3×	33	636
Megha Shettigar United States	3	355 0.8×	325 0.8×	174 0.7×	196 1.0×	72 0.7×	3	533
Candice Willmon United States	11	409 0.9×	566 1.4×	272 1.2×	132 0.7×	133 1.4×	17	683
Murielle Gantzer France	8	400 0.9×	620 1.6×	544 2.3×	209 1.0×	77 0.8×	13	915
Roshni Ravindranathan United States	12	805 1.8×	727 1.8×	337 1.4×	432 2.1×	157 1.6×	17	1.1k
Jacob P. van Vloten Canada	15	238 0.5×	234 0.6×	162 0.7×	215 1.1×	44 0.5×	32	640
Anagha P. Phadke United States	10	152 0.3×	207 0.5×	223 1.0×	124 0.6×	95 1.0×	14	527
Kyle B. Stephenson Canada	20	767 1.7×	778 2.0×	385 1.6×	502 2.5×	121 1.2×	27	1.3k
L A Sumerel United States	9	316 0.7×	489 1.2×	657 2.8×	323 1.6×	108 1.1×	10	919

Countries citing papers authored by Mathilde Feist

Since Specialization

Citations

This map shows the geographic impact of Mathilde Feist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Feist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Feist more than expected).

Fields of papers citing papers by Mathilde Feist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Feist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Feist. The network helps show where Mathilde Feist may publish in the future.

Co-authorship network of co-authors of Mathilde Feist

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Feist. A scholar is included among the top collaborators of Mathilde Feist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Feist. Mathilde Feist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Felsenstein, Matthäus, Mathilde Feist, Karl H. Hillebrandt, et al.. (2022). Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?. Journal of Clinical Medicine. 11(9). 2367–2367. 21 indexed citations

Yang, Min, Chao Feng, Mathilde Feist, et al.. (2021). IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity. Cancer Immunology Immunotherapy. 70(9). 2467–2481. 18 indexed citations

Felsenstein, Matthäus, Karl H. Hillebrandt, Mathilde Feist, et al.. (2021). Robot-assisted pancreatic surgery—optimized operating procedures: set-up, port placement, surgical steps. Journal of Robotic Surgery. 16(4). 807–814. 4 indexed citations

Kosaka, Hiromichi, Zuqiang Liu, Mathilde Feist, et al.. (2021). In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy. Frontiers in Immunology. 12. 610042–610042. 6 indexed citations

Feist, Mathilde, Zhi Zhu, Enyong Dai, et al.. (2020). Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy. Cancer Gene Therapy. 28(1-2). 98–111. 45 indexed citations

Schultheis, Beate, Dirk Strumberg, Jan Kuhlmann, et al.. (2020). Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study. Cancers. 12(11). 3130–3130. 48 indexed citations

Guo, Zong Sheng, Binfeng Lu, Mathilde Feist, et al.. (2019). Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics. Journal for ImmunoTherapy of Cancer. 7(1). 6–6. 234 indexed citations

Kowalsky, Stacy J., Zuqiang Liu, Mathilde Feist, et al.. (2018). Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade. Molecular Therapy. 26(10). 2476–2486. 118 indexed citations

Feist, Mathilde, et al.. (2018). Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC. Visceral Medicine. 34(4). 307–309. 1 indexed citations

10.

Liu, Zuqiang, Yan Ge, Haiyan Wang, et al.. (2018). Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2. Nature Communications. 9(1). 4682–4682. 66 indexed citations

11.

Guo, Zong Sheng, Zuqiang Liu, Stacy J. Kowalsky, et al.. (2017). Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives. Frontiers in Immunology. 8. 555–555. 72 indexed citations

12.

Brandl, Andreas, Sascha Weiß, Moritz von Winterfeld, et al.. (2017). Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience. International Journal of Hyperthermia. 34(5). 512–517. 13 indexed citations

13.

Feist, Mathilde, et al.. (2016). Intraoperative Chemotherapie. Der Onkologe. 22(9). 651–658.

14.

Feist, Mathilde, Xiaohua Huang, J. M. Müller, Beate Rau, & Wolfgang Dubiel. (2014). Can hyperthermic intraperitoneal chemotherapy efficiency be improved by blocking the DNA repair factor COP9 signalosome?. International Journal of Colorectal Disease. 29(6). 673–680. 11 indexed citations

15.

Mann, Sabine, et al.. (2013). Balling gun‐induced trauma in cattle: clinical presentation, diagnosis and prevention. Veterinary Record. 172(26). 685–685. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact